vs
Side-by-side financial comparison of IDEX Corporation (IEX) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $382.2M, roughly 1.0× LifeStance Health Group, Inc.). IDEX Corporation runs the higher net margin — 30.1% vs 3.1%, a 27.1% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 16.7%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $46.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs -29.4%).
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
IEX vs LFST — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $398.4M | $382.2M |
| Net Profit | $120.0M | $11.7M |
| Gross Margin | 99.9% | — |
| Operating Margin | 43.3% | 4.7% |
| Net Margin | 30.1% | 3.1% |
| Revenue YoY | 16.7% | 17.4% |
| Net Profit YoY | 25.7% | 264.1% |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | $398.4M | — | ||
| Q1 26 | $407.7M | — | ||
| Q4 25 | $899.1M | $382.2M | ||
| Q3 25 | $878.7M | $363.8M | ||
| Q2 25 | $865.4M | $345.3M | ||
| Q1 25 | $814.3M | $333.0M | ||
| Q4 24 | $862.9M | $325.5M | ||
| Q3 24 | $798.2M | $312.7M |
| Q2 26 | $120.0M | — | ||
| Q1 26 | $128.3M | — | ||
| Q4 25 | $128.3M | $11.7M | ||
| Q3 25 | $127.8M | $1.1M | ||
| Q2 25 | $131.6M | $-3.8M | ||
| Q1 25 | $95.5M | $709.0K | ||
| Q4 24 | $123.2M | $-7.1M | ||
| Q3 24 | $119.1M | $-6.0M |
| Q2 26 | 99.9% | — | ||
| Q1 26 | 94.9% | — | ||
| Q4 25 | 43.1% | — | ||
| Q3 25 | 44.5% | — | ||
| Q2 25 | 45.3% | — | ||
| Q1 25 | 45.3% | — | ||
| Q4 24 | 42.5% | — | ||
| Q3 24 | 44.3% | — |
| Q2 26 | 43.3% | — | ||
| Q1 26 | 45.0% | — | ||
| Q4 25 | 20.4% | 4.7% | ||
| Q3 25 | 21.1% | 2.0% | ||
| Q2 25 | 21.7% | -0.9% | ||
| Q1 25 | 17.4% | 0.5% | ||
| Q4 24 | 19.2% | 0.3% | ||
| Q3 24 | 21.0% | 0.0% |
| Q2 26 | 30.1% | — | ||
| Q1 26 | 31.5% | — | ||
| Q4 25 | 14.3% | 3.1% | ||
| Q3 25 | 14.5% | 0.3% | ||
| Q2 25 | 15.2% | -1.1% | ||
| Q1 25 | 11.7% | 0.2% | ||
| Q4 24 | 14.3% | -2.2% | ||
| Q3 24 | 14.9% | -1.9% |
| Q2 26 | $1.61 | — | ||
| Q1 26 | $1.71 | — | ||
| Q4 25 | $1.71 | — | ||
| Q3 25 | $1.70 | — | ||
| Q2 25 | $1.74 | — | ||
| Q1 25 | $1.26 | — | ||
| Q4 24 | $1.61 | — | ||
| Q3 24 | $1.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $586.2M | $248.6M |
| Total DebtLower is stronger | — | $282.8M |
| Stockholders' EquityBook value | $4.0B | $1.5B |
| Total Assets | $6.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $586.2M | — | ||
| Q1 26 | $580.0M | — | ||
| Q4 25 | $580.0M | $248.6M | ||
| Q3 25 | $593.8M | $203.9M | ||
| Q2 25 | $568.2M | $188.9M | ||
| Q1 25 | $594.1M | $134.3M | ||
| Q4 24 | $620.8M | $154.6M | ||
| Q3 24 | $633.2M | $102.6M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $282.8M | ||
| Q3 25 | $1.9B | $284.6M | ||
| Q2 25 | $1.9B | $286.4M | ||
| Q1 25 | $2.0B | $288.2M | ||
| Q4 24 | $2.0B | $290.0M | ||
| Q3 24 | $2.1B | $287.3M |
| Q2 26 | $4.0B | — | ||
| Q1 26 | $4.0B | — | ||
| Q4 25 | $4.0B | $1.5B | ||
| Q3 25 | $4.0B | $1.5B | ||
| Q2 25 | $4.0B | $1.5B | ||
| Q1 25 | $3.9B | $1.5B | ||
| Q4 24 | $3.8B | $1.4B | ||
| Q3 24 | $3.8B | $1.4B |
| Q2 26 | $6.9B | — | ||
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.9B | $2.2B | ||
| Q3 25 | $7.0B | $2.1B | ||
| Q2 25 | $6.9B | $2.1B | ||
| Q1 25 | $6.8B | $2.1B | ||
| Q4 24 | $6.7B | $2.1B | ||
| Q3 24 | $7.0B | $2.1B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | 0.19× | ||
| Q3 25 | 0.48× | 0.19× | ||
| Q2 25 | 0.46× | 0.19× | ||
| Q1 25 | 0.50× | 0.20× | ||
| Q4 24 | 0.52× | 0.20× | ||
| Q3 24 | 0.55× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $57.6M |
| Free Cash FlowOCF − Capex | $86.0M | $46.6M |
| FCF MarginFCF / Revenue | 21.6% | 12.2% |
| Capex IntensityCapex / Revenue | 4.4% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | $654.3M | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $209.5M | $57.6M | ||
| Q3 25 | $203.5M | $27.3M | ||
| Q2 25 | $161.7M | $64.4M | ||
| Q1 25 | $105.7M | $-3.1M | ||
| Q4 24 | $172.6M | $62.3M | ||
| Q3 24 | $205.3M | $22.7M |
| Q2 26 | $86.0M | — | ||
| Q1 26 | $189.8M | — | ||
| Q4 25 | $189.8M | $46.6M | ||
| Q3 25 | $188.7M | $17.0M | ||
| Q2 25 | $146.9M | $56.6M | ||
| Q1 25 | $91.4M | $-10.3M | ||
| Q4 24 | $157.1M | $56.0M | ||
| Q3 24 | $191.6M | $17.7M |
| Q2 26 | 21.6% | — | ||
| Q1 26 | 46.6% | — | ||
| Q4 25 | 21.1% | 12.2% | ||
| Q3 25 | 21.5% | 4.7% | ||
| Q2 25 | 17.0% | 16.4% | ||
| Q1 25 | 11.2% | -3.1% | ||
| Q4 24 | 18.2% | 17.2% | ||
| Q3 24 | 24.0% | 5.7% |
| Q2 26 | 4.4% | — | ||
| Q1 26 | 15.6% | — | ||
| Q4 25 | 2.2% | 2.9% | ||
| Q3 25 | 1.7% | 2.8% | ||
| Q2 25 | 1.7% | 2.2% | ||
| Q1 25 | 1.8% | 2.2% | ||
| Q4 24 | 1.8% | 1.9% | ||
| Q3 24 | 1.7% | 1.6% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.63× | 4.93× | ||
| Q3 25 | 1.59× | 25.34× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.11× | -4.36× | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.72× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
